Talk:Human T-lymphotropic virus 1

Viruses High‑importance

	Viruses portal This article is within the scope of WikiProject Viruses, a collaborative effort to improve the coverage of viruses on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.VirusesWikipedia:WikiProject VirusesTemplate:WikiProject Virusesvirus articles
High	This article has been rated as High-importance on the project's importance scale.

Medicine: Hematology-oncology High‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
High	This article has been rated as High-importance on the project's importance scale.
	This article is supported by the Hematology-oncology task force.

Human T-lymphotropic virus 1 received a peer review by Wikipedia editors, which is now archived. It may contain ideas you can use to improve this article.

Need merged?

Human T-lymphotropic virus seems to explain better than this page.tosendo (talk) 12:39, 14 December 2011 (UTC)[reply]

Source for virus rename

Can anyone provide a reference for the statement the name HTLV-III (aka HIV) has been reused to name a different virus? I can find no credible reference for this statement.el Chingón 13:57, 22 April 2006 (UTC)[reply]

The reference appears to have been added. -- Beland (talk)

Treatment

As with other infectious virii i believe this page should include current and proposed treatment plans. 81.105.162.252 (talk) 13:11, 23 June 2008 (UTC)[reply]

Mechanism HTLV-1 —Preceding unsigned comment added by 62.240.40.175 (talk) 09:13, 14 September 2008 (UTC)[reply]

If so, the article should explain that more clearly. I've created a Treatment section to this end. Is there a reference for the claim that there is no effective treatment? The article seems to imply that anti-retrovirals help. It should be stated explicitly whether or not an infection can be cured, as with early aggressive HIV anti-retroviral therapy. Info about any serious work toward producing potential future treatments would also be relevant. -- Beland (talk) 02:34, 3 December 2008 (UTC)[reply]

I have added more information to the treatment section on the treatment of adult-T cell lymphoma that can result from this virus,and the treatment of HLTV myelopathy.My current impression is that their is no effective antiviral drug for the treatment of HLTV infection.Immunize (talk) 23:52, 14 January 2010 (UTC)[reply]

Htlv1 glycoprotein su TM cell cultivation vacines UNESCO unisef ran trials in 2010-2011 2A02:C7E:2873:B700:58B2:89F3:1563:A0A2 (talk) 04:30, 24 March 2024 (UTC)[reply]

Prevalence of symptoms

HTLV-I seems remarkably common, and yet I've heard little about it. How often does it result it any disease? -- Beland (talk) 02:46, 3 December 2008 (UTC)[reply]

Spreaded by transmission rabies slavia in dogs

spreades by transmission of rabies slavia in dogs htlv1 in animal models unesco unisef vaccinated su TM glycoproteins with htlv1 glycoprotein vacines weather infective or affective was not known as scientists didn't do the appropriate studies 2A02:C7E:2873:B700:58B2:89F3:1563:A0A2 (talk) 04:26, 24 March 2024 (UTC)[reply]

Some removal of sourced information

@Bensonandhedges, I don't quite understand this edit. Why was some sourced information removed, and some unsourced information added? Nakonana (talk) 23:19, 13 July 2024 (UTC)[reply]

Information removed:

The epidemiology of HTLV-1 has been fairly well established across many countries globally. It's very odd to say knowledge is "limited".
The first statement regarding Japan as having the highest prevalence for any country is also incorrect. Many west African countries, Latin American countries, Caribbean countries, Melanesian and Asutraliasian countries have substantially higher prevalence than Japan.
I added valuable information on the epidemiological characteristics of HTLV-1, before proceeding to state prevalences for various regions. Previously, the Epi section dived straight into country rates, without much information on the general patterns and distribution characteristics typical of HTLV-1. Im happy to add citations. But these amendments enhance the readability and accuracy of the article.

Bensonandhedges (talk) 00:48, 16 July 2024 (UTC)[reply]